Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

24.03.2025

4 BMC Cancer
3 BMC Gastroenterol
4 Dig Dis Sci
3 Eur Radiol
8 Hepatology
1 Int J Cancer
1 J Comput Assist Tomogr
1 J Gastroenterol
6 J Hepatol
1 PLoS Genet
3 PLoS One
1 Radiology
1 Transplant Proc



    BMC Cancer

  1. SU Y, Liang Y, Zhong D, Yan H, et al
    Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy.
    BMC Cancer. 2025;25:504.
    >> Share

  2. SONG S, Zhang G, Yao Z, Chen R, et al
    Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma.
    BMC Cancer. 2025;25:497.
    >> Share

  3. WANG Y, Yang Z, Li Z, Huang L, et al
    Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in colorectal cancer.
    BMC Cancer. 2025;25:480.
    >> Share

  4. TANG H, Chai C, Miao X, Su Y, et al
    Establishment and characterization of CHC-X1: the third human combined hepatocellular-cholangiocarcinoma cell line.
    BMC Cancer. 2025;25:472.
    >> Share


    BMC Gastroenterol

  5. ZHANG L, Bai L
    Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for colorectal liver metastases: a case-control study.
    BMC Gastroenterol. 2025;25:188.
    >> Share

  6. YU C, Chen L, Hu W, Lei X, et al
    The role of the advanced lung cancer inflammation index (ALI) in the risk of liver fibrosis and mortality among US adult MAFLD patients: a cross-sectional study of NHANES 1999-2018.
    BMC Gastroenterol. 2025;25:190.
    >> Share

  7. ZHANG W, Kang N, Wang Y, Zhang F, et al
    Endoscopic treatment for gastroesophageal varices in patients with cirrhosis: a survey comparing between developed and developing countries.
    BMC Gastroenterol. 2025;25:176.
    >> Share


    Dig Dis Sci

  8. PIETRI O, Chicaud M, Andreani T, Chretien Y, et al
    Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of Seven.
    Dig Dis Sci. 2025;70:1178-1189.
    >> Share

  9. ZHANG J, Yang Z, Liu X, Yang X, et al
    New Insights into the Pathogenesis of Alcoholic Liver Disease Based on Global Research.
    Dig Dis Sci. 2025;70:903-918.
    >> Share

  10. CHIEN SC, Chiu HC, Chiu YC, Wang RH, et al
    Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD).
    Dig Dis Sci. 2025;70:1190-1200.
    >> Share

  11. JAGDISH B, Murone J, Venkat D
    Implementation of Alcohol Use Disorder Training Curriculum Improves Perceived Confidence in Treating Alcohol-Related Liver Disorder Amongst Gastroenterology Fellows.
    Dig Dis Sci. 2025;70:1000-1007.
    >> Share


    Eur Radiol

  12. CANNELLA R, Agnello F, Porrello G, Spinello AU, et al
    Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease.
    Eur Radiol. 2025;35:2339-2350.
    >> Share

  13. REITHMEIER B, Laun FB, Fuhres T, Uder M, et al
    Relevance of lesion size in navigator-triggered and free-breathing diffusion-weighted liver MRI.
    Eur Radiol. 2025;35:2106-2115.
    >> Share

  14. ZHANG Y, Huang C, Meng F, Hu X, et al
    Non-invasive assessment of esophageal and fundic varices in patients with primary biliary cholangitis.
    Eur Radiol. 2025;35:2330-2338.
    >> Share


    Hepatology

  15. GE J, Fontil V, Ackerman S, Pletcher MJ, et al
    Clinical decision support and electronic interventions to improve care quality in chronic liver diseases and cirrhosis.
    Hepatology. 2023 Aug 23. doi: 10.1097/HEP.0000000000000583.
    >> Share

  16. ZANUSO V, Rimassa L, Braconi C
    The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy.
    Hepatology. 2025;81:1365-1386.
    >> Share

  17. STALLER DW, Panigrahi SS, Jayasinghe YP, Dong Y, et al
    A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases.
    Hepatology. 2025;81:1288-1303.
    >> Share

  18. HLADY RA, Zhao X, El Khoury LY, Wagner RT, et al
    Epigenetic heterogeneity hotspots in human liver disease progression.
    Hepatology. 2025;81:1197-1210.
    >> Share

  19. LEFERE S, Mosca A, Hudert C, Dupont E, et al
    Development and validation of pFIB scores for exclusion of significant liver fibrosis in pediatric MASLD.
    Hepatology. 2025;81:1276-1287.
    >> Share

  20. OJHA U, Kim S, Rhee CY, You J, et al
    Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis.
    Hepatology. 2025;81:1228-1243.
    >> Share

  21. WANG M, Chiou SH, Ganger D, Ruck J, et al
    Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study.
    Hepatology. 2024 Jul 24. doi: 10.1097/HEP.0000000000001030.
    >> Share

  22. NOBEL YR, Boike JR, Mazumder NR, Thornburg B, et al
    Predictors of long-term clinical outcomes after TIPS: An ALTA group study.
    Hepatology. 2025;81:1244-1255.
    >> Share


    Int J Cancer

  23. PATEL DP, Loffredo CA, Pupacdi B, Rabibhadana S, et al
    Associations of chronic liver disease and liver cancer with glyphosate and its metabolites in Thailand.
    Int J Cancer. 2025;156:1885-1897.
    >> Share


    J Comput Assist Tomogr

  24. SETIAWAN H, Ria F, Abadi E, Marin D, et al
    Development and Clinical Evaluation of a Contrast Optimizer for Contrast-Enhanced CT Imaging of the Liver.
    J Comput Assist Tomogr. 2025;49:239-246.
    >> Share


    J Gastroenterol

  25. HANAMATSU H, Suda G, Ohara M, Ogawa K, et al
    Elevated A2F bisect N-glycans of serum IgA reflect progression of liver fibrosis in patients with MASLD.
    J Gastroenterol. 2025;60:456-468.
    >> Share


    J Hepatol

  26. RAN S, Zhang J, Tian F, Qian ZM, et al
    Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study.
    J Hepatol. 2025;82:560-570.
    >> Share

  27. YANG X, Deng B, Zhao W, Guo Y, et al
    FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity.
    J Hepatol. 2025;82:676-689.
    >> Share

  28. BURKE L, Bernal W, Pirani T, Agarwal B, et al
    Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort.
    J Hepatol. 2025;82:615-621.
    >> Share

  29. VILAR-GOMEZ E, Gawrieh S, Vuppalanchi R, Kettler C, et al
    PNPLA3 rs738409, environmental factors and liver-related mortality in the US population.
    J Hepatol. 2025;82:571-581.
    >> Share

  30. MEIJNIKMAN AS, Fondevila MF, Arrese M, Kisseleva T, et al
    Towards more consistent models and consensual terminology in preclinical research for steatotic liver disease.
    J Hepatol. 2025;82:760-766.
    >> Share

  31. ARAB JP, Diaz LA, Rehm J, Im G, et al
    Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease.
    J Hepatol. 2025;82:744-756.
    >> Share


    PLoS Genet

  32. CHEN L, Yang H, Wang J, Zhang H, et al
    MEOX1-mediated transcriptional regulation of circABHD3 exacerbates hepatic fibrosis through promoting m6A/YTHDF2-dependent YPEL3 mRNA decay to activate beta-catenin signaling.
    PLoS Genet. 2025;21:e1011622.
    >> Share


    PLoS One

  33. ADEYEMI O, Osuntoki A, Magbagbeola O, Abdel Hamid MM, et al
    Evidence for infectious merozoites of Plasmodium falciparum from natural isolates of cultured hepatoma cells infected with sporozoites.
    PLoS One. 2025;20:e0319901.
    >> Share

  34. CHEN K, Yang M, Li G, Wang W, et al
    Liver transplantation for NASH-related hepatocellular carcinoma versus non-NASH etiologies of hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0317730.
    >> Share

  35. LIN L, Xie Y, Lin Z, Lin C, et al
    Machine learning for predicting metabolic-associated fatty liver disease including NHHR: a cross-sectional NHANES study.
    PLoS One. 2025;20:e0319851.
    >> Share


    Radiology

  36. DELL T, Mesropyan N, Layer Y, Tischler V, et al
    Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study.
    Radiology. 2025;314:e241677.
    >> Share


    Transplant Proc

  37. WANG H, Qu W, Liu Y, Zhang L, et al
    Recurrence of Myopathy After Liver Transplantation for Patients With End-Stage GSD Type IIIa.
    Transplant Proc. 2025 Mar 3:S0041-1345(25)00093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016